ArticlePathology oncology research : POR2023

CVM-1118 (foslinanib), a 2-phenyl-4-quinolone derivative, promotes apoptosis and inhibits vasculogenic mimicry via targeting TRAP1.

Lifen Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.